IAK iShares U.S. Insurance ETF

iShares U.S. Insurance ETF (IAK) currently reports 57 stock positions (subject to change), placing it in the neither concentrated nor index-like range by holdings breadth. The top line-up is CB (13.71%), PGR (13.44%), TRV (7.29%), with CB as the largest single weight at 13.71%. Together, the top three holdings account for 34.44%, which indicates that performance attribution will be heavily shaped by the top few positions rather than the broader basket. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.

From a returns-on-capital standpoint, ROIC is 14.50%, WACC is 6.42%, and the economic spread is 8.08%. On balance, the portfolio clears its capital cost hurdle modestly — value creation is present but not emphatic. Supporting metrics show ROE at 19.77% and ROA at 3.76%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

The current pricing of the underlying holdings reads trailing P/E of 10.90, forward P/E of 10.57, PEG of 3.39. The small spread between trailing and forward P/E suggests neither meaningful acceleration nor deterioration is currently priced into the earnings outlook. The PEG reading here is above the range most value-oriented investors would find comfortable — the valuation requires a high degree of confidence in forward earnings delivery. The aggregate current ratio of 1.19 points to tighter short-term liquidity across the portfolio. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

On profitability at each income statement layer, gross margin sits at 32.29%, operating margin at 17.29%, and free cash flow margin at 21.07%. Gross margins are moderate, pointing to holdings where unit economics are functional but not a source of structural advantage. At this operating margin level, the holdings demonstrate competent cost management and reasonable earnings durability. Free cash flow margins are strong, reflecting capital-efficient businesses that largely self-fund their growth. Taken together, the margin stack suggests quality that is uneven — some layers are more resilient than others, and that asymmetry matters under stress.

Looking at growth and market-implied direction, TTM revenue growth of 11.30% indicating top-line growth that is constructive without being speculative. At the same time, the estimated 12-month price change of 10.57%, where implied upside appears constructive but not aggressive. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The metrics do not present an obvious case for aggressive action in either direction, and a measured, monitoring posture is appropriate given the current mix of signals.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.